Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational Mastitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
300 participants
Aug 28, 2024
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to evaluate the validity and reliability of the Mastitis-score (M-score) and the Breast Inflammatory Symptom Severity Index (BISSI) as measures for assessing symptom severity in non-lactational granulomatous lobular/periductal mastitis (NL-GLM/PDM). This research aims to provide a valid and reliable tool for evaluating both symptom severity and treatment efficacy in NL-GLM/PDM.
Eligibility
Inclusion Criteria5
- Female, age between 18 and 65 years;
- Clinically considered as Non-Lactational mastitis;
- Clinically and Pathologically confirmed NL-GLM/PDM;
- Patients planning to receive treatment or observation alone;
- Signed the informed consent form
Exclusion Criteria3
- Patients with confirmed or suspected malignant breast tumors
- Patients with bilateral mastitis (including those with bilateral Non-Lactational Mastitis occurring simultaneously or successively)
- Pregnant.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants may receive any treatments in accordance with standard clinical practice, based on physicians' recommendations and patients' preferences.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06667609